HIV vaccine (CDC/National Vaccine and Serum Institute)

DNA-天坛痘苗复合型艾滋病疫苗

Report date: 2026/03/20 20:03:07

Base Information

Drug NameHIV vaccine (CDC/National Vaccine and Serum Institute)
Drug Alias Name艾滋病疫苗(核酸与重组天坛痘苗联合使用)Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan(CDC/National Vaccine and Serum Institute)DNA prime/rTV boost HIV vaccine (CDC/National Vaccine and Serum Institute)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)Beijing Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChinese Center For Aids/Std Control And Prevention, China CdcBeijing Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A